Where is Kymab headquartered?

Kymab is located in Cambridge, england.

Who invested in Kymab?

Kymab has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Kymab?

Kymab closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

kymab.com

Kymab

Kymab is a biotechnology firm that develops and commercializes human antibody-based therapeutics for the treatment of infectious diseases.

Business Model:

Revenue: $195.7M

Employees: 1,001-5,000

Kymab was acquired by Sanofi.
The acquisition happend on 2021-01-11.
Details of the transaction were not public

Acquirer

Sanofi

General Information

Geographic Data

Address: Babraham Research Campus

City: Cambridge

State: england

Zip: CB22 3AT

Country: GB

Financial Info

Stage:

grant

Raised Last:

$9M

Raised Total:

$229M

Social

Facebook

Twitter

Crunchbase

Metrics

3,639,152Website Global Rank

3,905Website Monthly Traffic

Twitter Followers

Description

Kymab is a biotechnology firm that develops and commercializes human antibody-based therapeutics for the treatment of infectious diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
6/2012	Series A		$30M
7/2010	Series A	1	$30.4M	Wellcome Trust Wellcome Trust
1/2017	Grant	1	$9M	Bill &a; Melinda Gates Foundation Bill &a; Melinda Gates Foundation Bill &a; Melinda Gates Foundation Bill &a; Melinda Gates Foundation
5/2015	Series B	2	$50M	Malin Corporation Woodford Investment Management Malin Corporation Malin Corporation Woodford Investment Management Malin Corporation
5/2014	Series B	2	$40M	Wellcome Trust Wellcome Trust Bill &a; Melinda Gates Foundation Wellcome Trust Wellcome Trust
11/2016	Series C		$0	Bill &a; Melinda Gates Foundation Hepalink Malin Corporation ORI Capital Wellcome Trust Woodford Investment Management Bill &a; Melinda Gates Foundation Hepalink Malin Corporation ORI Capital Wellcome Trust Woodford Investment Management
11/2016	Series C	6	$100M	Shenzhen Hepalink Pharmaceutical Co., Ltd The Wellcome Trust Bill & Melinda Gates Foundation Malin Corporation plc Woodford Patient Capital plc. Malin Corporation Woodford Investment Management Wellcome Trust Bill &a; Melinda Gates Foundation Hepalink ORI Capital ORI Capital

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details